Value through Innovation27 July 2016

Clinical Study Results

  • ANTISTAX ® - Venous Insufficiency
    Clinical Study Number 1138.10
    Study Indication Venous Insufficiency
    Product ANTISTAX ®
    Generic Name Vitis vinifera
    Lab Code
    Clinical Phase III
    Study Title

    A 12-week, double-blind, randomised, placebo-controlled, multicentre trial to evaluate efficacy and tolerability of Antistax® film-coated tablets, 360 mg/day orally, in male and female patients suffering from chronic venous insufficiency

    Study Document Trial synopsis 1138.10_CO english
  • ANTISTAX ® - Venous Insufficiency
    Clinical Study Number 1138.11
    Study Indication Venous Insufficiency
    Product ANTISTAX ®
    Generic Name Vitis vinifera
    Lab Code
    Clinical Phase III
    Study Title

    A 12-week, double-blind, randomised, placebo-controlled, multicentre trial to evaluate efficacy and tolerability of Antistax® film coated tablets, 720 mg/day orally, in male and female patients suffering from chronic venous insufficiency

    Study Document Trial synopsis 1138.11_DR english
  • ANTISTAX ® - Venous Insufficiency
    Clinical Study Number 1138.2
    Study Indication Venous Insufficiency
    Product ANTISTAX ®
    Generic Name Vinitis vinifera
    Lab Code
    Clinical Phase II
    Study Title

    The ability of Antistax® to improve Chronic Venous Insufficiency (CVI) I and II in male and female patients: a dose response study

    Study Document Trial synopsis 1138.2 english
  • ANTISTAX ® - Venous Insufficiency
    Clinical Study Number 1138.3
    Study Indication Venous Insufficiency
    Product ANTISTAX ®
    Generic Name Vinitis vinifera
    Lab Code
    Clinical Phase II
    Study Title

    A 17 week, randomised, double-blind, placebo controlled cross-over trial to evaluate the efficacy of Antistax ® film coated tablets (Extr. Vitis vinitera siccum), 360 mg/day p.o. in improving microcirculation of the skin in the leg of male and female patients suffering trom chronic venous insufficiency

    Study Document Trial synopsis 1138.3 english
  • ANTISTAX ® - Venous Insufficiency
    Clinical Study Number 1138.4
    Study Indication Venous Insufficiency
    Product ANTISTAX ®
    Generic Name Vinitis vinifera
    Lab Code
    Clinical Phase III
    Study Title

    A 12-week, double-blind, randomised, placebo-controlled, multicentre trial to evaluate efficacy and tolerability of Antistax® film coated tablets, 360 mg/day orally, in male and female patients suffering from chronic venous insufficiency

    Study Document Trial synopsis 1138.4 english
  • ANTISTAX ® - Venous Insufficiency
    Clinical Study Number 1138.5
    Study Indication Venous Insufficiency
    Product ANTISTAX ®
    Generic Name Vinitis vinifera
    Lab Code
    Clinical Phase IIIb/IV
    Study Title

    A 6-week, open, multicentre safety trial to evaluate the tolerability profile of Antistax® film coated tablets (extr. Vitis viniferae siccum), 360 mg/day per os, in male and female patients suffering from chronic venous insufficiency

    Study Document Trial synopsis 1138.5 english
  • ANTISTAX ® - Venous Insufficiency
    Clinical Study Number 1138.6
    Study Indication Venous Insufficiency
    Product ANTISTAX ®
    Generic Name Vinitis vinifera
    Lab Code
    Clinical Phase III
    Study Title

    Clinical Study of BNS003 on Swelling due to Disorder of Leg Venous Reflux

    Study Document Trial synopsis 1138.6_CO english
  • ANTISTAX ® - Healthy
    Clinical Study Number 1138.9
    Study Indication Healthy
    Product ANTISTAX ®
    Generic Name Vinitis vinifera
    Lab Code
    Clinical Phase I
    Study Title

    An open, uncontrolled trial in healthy volunteers to explore the plasma and urinary pharmacokinetics of a single oral dose of 1,800 mg Red Vine Leaf Extract (Antistax®)

    Study Document Trial synopsis 1138.9_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.